Literature DB >> 11694191

Functional development of engineered skeletal muscle from adult and neonatal rats.

P E Kosnik1, J A Faulkner, R G Dennis.   

Abstract

A myooid is a three-dimensional skeletal muscle construct cultured from mammalian myoblasts and fibroblasts. The purpose was to compare over several weeks in culture the morphology, excitability, and contractility of myooids developed from neonatal and adult rat cells. The hypotheses tested were as follows: (1) baseline forces of myooids correlate with the cross-sectional area (CSA) of the myooids composed of fibroblasts, and (2) peak isometric tetanic forces normalized by total CSA (specific P(o)) of neonatal and adult rat myooids are not different. Electrical field stimulation was used to measure the excitability and peak tetanic forces. The proportion of the CSA composed of fibroblasts was greater for neonatal (40%) than adult (17%) myooids. For all myooids the baseline passive force normalized by fibroblast CSA (mean = 5.5 kPa) correlated with the fibroblast CSA (r(2) = 0.74). A two-element cylindrical model was analyzed to determine the contributions of fibroblasts and myotubes to the baseline force. At each measurement period, the specific P(o) of the adult myooids was greater than that of the neonatal myooids. The specific P(o) of the adult myooids was approximately 1% of the control value for adult muscles and did not change with time in culture, while that of neonatal myooids increased.

Entities:  

Mesh:

Year:  2001        PMID: 11694191     DOI: 10.1089/107632701753213192

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  27 in total

1.  Effect of microRNA modulation on bioartificial muscle function.

Authors:  Caroline Rhim; Cindy S Cheng; William E Kraus; George A Truskey
Journal:  Tissue Eng Part A       Date:  2010-08-28       Impact factor: 3.845

2.  Functional evaluation of nerve-skeletal muscle constructs engineered in vitro.

Authors:  Lisa M Larkin; Jack H Van der Meulen; Robert G Dennis; Jeffrey B Kennedy
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Mar-Apr       Impact factor: 2.416

3.  Photolithographic patterning of C2C12 myotubes using vitronectin as growth substrate in serum-free medium.

Authors:  Peter Molnar; Weishi Wang; Anupama Natarajan; John W Rumsey; James J Hickman
Journal:  Biotechnol Prog       Date:  2007 Jan-Feb

4.  Implanted scaffold-free prevascularized constructs promote tissue repair.

Authors:  Caitlin A Czajka; Bennet W Calder; Michael J Yost; Christopher J Drake
Journal:  Ann Plast Surg       Date:  2015-03       Impact factor: 1.539

5.  Structure and functional evaluation of tendon-skeletal muscle constructs engineered in vitro.

Authors:  Lisa M Larkin; Sarah Calve; Tatiana Y Kostrominova; Ellen M Arruda
Journal:  Tissue Eng       Date:  2006-11

Review 6.  Engineering orthopedic tissue interfaces.

Authors:  Peter J Yang; Johnna S Temenoff
Journal:  Tissue Eng Part B Rev       Date:  2009-06       Impact factor: 6.389

7.  Correlation of embryonic skeletal muscle myotube physical characteristics with contractile force generation on an atomic force microscope-based bio-microelectromechanical systems device.

Authors:  K L Pirozzi; C J Long; C W McAleer; A S T Smith; J J Hickman
Journal:  Appl Phys Lett       Date:  2013-08-20       Impact factor: 3.791

8.  Bioengineered three-dimensional physiological model of colonic longitudinal smooth muscle in vitro.

Authors:  Shreya Raghavan; Mai T Lam; Lesley L Foster; Robert R Gilmont; Sita Somara; Shuichi Takayama; Khalil N Bitar
Journal:  Tissue Eng Part C Methods       Date:  2010-10       Impact factor: 3.056

9.  Effect of streptomycin on the active force of bioengineered heart muscle in response to controlled stretch.

Authors:  R K Birla; Y C Huang; R G Dennis
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-06-21       Impact factor: 2.416

10.  Proliferation of myoblast skeletal cells on three-dimensional supermacroporous cryogels.

Authors:  Deepti Singh; Vijayashree Nayak; Ashok Kumar
Journal:  Int J Biol Sci       Date:  2010-07-03       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.